Viridian Therapeutics Eulerpool Ziņas

Viridian Therapeutics Eulerpool News

Viridian Therapeutics Akciju Ziņas

Viridian Therapeutics tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Viridian Therapeutics ziņas mēs apkopojam šeit.

• 25. jūlijs ·

  Yahoo
  Viridian Therapeutics Announces Completion of THRIVE-2 Enrollment for VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED)
• 25. jūlijs ·

  Thefly.com
  Viridian Therapeutics completes enrollment in THRIVE-2 trial
• 18. jūlijs ·

  TipRanks
  Buy Rating for Viridian Therapeutics on VRDN-001 Clinical Advancements and Market Potential
• 16. jūlijs ·

  Thefly.com
  Wedbush reveals three potential buyout targets for Biogen
• 3. jūlijs ·

  Yahoo
  Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 20. jūnijs ·

  TipRanks
  Viridian Therapeutics’ Shareholders Approve Equity Plan Expansion
• 12. jūnijs ·

  SeekingAlpha
  Viridian Therapeutics: Key Catalysts Coming In The Second Half Of The Year
• 12. jūnijs ·

  TipRanks
  Ladenburg Thalmann & Co. Remains a Hold on Viridian Therapeutics (VRDN)
• 11. jūnijs ·

  TipRanks
  Analysts Offer Insights on Healthcare Companies: Longboard Pharmaceuticals (LBPH) and Viridian Therapeutics (VRDN)
• 11. jūnijs ·

  Yahoo
  Viridian Therapeutics Announces Details of Subcutaneous VRDN-003 Phase 3 Clinical Program for Patients with Active and Chronic Moderate-to-Severe Thyroid Eye Disease